Accrol Group Holdings Growth will be multifaceted say Zeus Capital (Analyst Interview)

Accrol Group Holdings plc (LON:ACRL) is the topic of conversation when Mike Allen, Head of Research at Zeus Capital joins DirectorsTalk. With the company producing is half year trading update Mike talks us through the key drivers, talks about the potential for growth, changes to the forecast and how he views the company in terms of a valuation.

Accrol Group Holdings said that the Group’s progress continues with all aspects of the business performing well. Margins are continuing to improve, and further improvements are expected, generating increasingly strong cash flows and reducing net debt at a faster rate than anticipated.

Click to view all articles for the EPIC: ,
Or click to view the full company profile:
Facebook
Twitter
LinkedIn
Accrol Group Holdings plc

More articles like this

Accrol Group

British manufacturing sees surge in sales and job creation

British manufacturing is witnessing a Brexit boost as sales rocket in the EU, Middle East and Far East, and the lifeblood of the UK economy flows once more. Major players in automotive, aerospace, construction, electrification, and

Accrol Group

Greenarc partnered with Accrol to install onsite EV chargers

Accrol Group Holdings plc (LON:ACRL) is the UK’s leading independent tissue converter, producing toilet tissue, kitchen towel, facial tissue and biodegradable wet wipes. The UK soft tissue market is worth £1.6bn with private label products comprising

Accrol Group

UK manufacturing industry sees £48.5bn productivity boost in 2023

The UK manufacturing industry achieved productivity improvements worth £48.5bn in 2023, according to analysis of ONS data by Fourjaw Manufacturing Analytics, a technology company that measures machine productivity. This represents an 8.6% increase on 2022 levels

Accrol Group

Accrol Group returns to profit

Accrol Group, the Blackburn-based AIM-listed tissue and toilet roll maker, has achieved a return to profit, despite a dip in revenues, for its interim period of trading. In the six months to October 31, 2023, the